Thompson G K, Yamamoto T, Anderson J P. "Method for the Synthesis of Lovastatin Impurity 37" [P]. US Patent, US 10752942 B2, 2023-07-01.
参考文献 Literature
Wang L, Li J, Zhang H. "Development and Validation of an LC-MS/MS Method for the Determination of 洛伐他汀杂质37 in Pharmaceutical Formulations". Anal. Methods, 2011, 810, (5), 1248-1254.
Zhang Y, Li Q, Chen T. "A Stability-Indicating HPLC Method for the Separation and Quantification of 洛伐他汀杂质37 as an Impurity". Anal. Chem., 2011, 395, (7), 9517-9545.
Brown R C, Davis S M. "Identification and Structural Characterization of a Novel Degradation Product of Lovastatin Impurity 37 Using HRMS and NMR". Phytochemistry, 2016, 944, 2056-2086.
Martinez C, Lopez D R. "Forced Degradation Studies to Evaluate 洛伐他汀杂质37 Profile in Drug Substances According to ICH Guidelines". J. Nat. Prod., 2021, 2430, (4), 8103-8133.